TY - JOUR
T1 - Pain, Agitation, Delirium, and Iatrogenic Withdrawal Syndrome Management in Children Who Are Critically Ill: Protocol for a European Clinical Practice Guideline Using the Grading of Recommendations Assessment, Development, and Evaluation Approach
AU - MacDonald, Ibo
AU - Cavin-Trombert, Alexia
AU - Jaques, Cécile
AU - De Clifford-Faugère, Gwenaëlle
AU - De Cock, Pieter A
AU - de Wildt, Saskia N
AU - Dmytriiev, Dmytro
AU - Engel, Juliane
AU - Fazio, Paola Claudia
AU - George, Sylvia
AU - Goyer, Isabelle
AU - Harðardóttir, Anna
AU - Harris, Julia
AU - Horváth, Klára
AU - Ista, Erwin
AU - Mencía, Santiago
AU - Metsvaht, Tuuli
AU - Mondardini, Maria Cristina
AU - Oualha, Mehdi
AU - Perez, Maria-Helena
AU - Pietrzkiewicz, Krzysztof
AU - Sperotto, Francesca
AU - Wyness, Benjamin
AU - Yalındağ, Nilüfer
AU - Amigoni, Angela
AU - Ramelet, Anne-Sylvie
PY - 2025/9/8
Y1 - 2025/9/8
N2 - In pediatric intensive care units, pain, sedation, delirium, and iatrogenic withdrawal syndrome (IWS) must be managed as interrelated conditions. Although clinical practice guidelines (CPGs) exist, new evidence needs to be incorporated, gaps in recommendations addressed, and recommendations adapted to the European context. This protocol describes the development of the first patient- and family-informed European guideline for managing pain, sedation, delirium, and IWS by the European Society of Paediatric and Neonatal Intensive Care. This guideline will follow the Grading of Recommendations Assessment, Development, and Evaluation ADOLOPMENT approach across seven phases: (1) setup-establish 3 groups, namely a steering committee, development panel (experts and patient and family partners), and patient and family partner advisory panel, to define guideline scope through voting and consensus; (2) preparation-vote on 30 summary recommendations compiled from existing CPGs of medium quality or above; prioritize new research questions; update the search for CPGs to match new research questions with recommendations using population, intervention, comparator, and outcome elements; prioritize outcomes for effectiveness questions using a 9-point Likert scale; with validation from patient and family partners; (3) evidence identification, analysis, and data extraction-develop individualized search strategies for each research question (2 independent appraisers will select and appraise studies and conduct data extraction); (4) evidence synthesis-expert pairs will summarize findings in evidence profiles and evidence-to-decision (EtD) frameworks (in the absence of evidence, the expert panel will be surveyed to assess current practices); (5) guideline development-expert pairs will draft recommendations, then topic-specific subgroups will reach consensus before full development panel voting (>80% approval needed; subgroups will determine the need for additional supporting content); (6) review-conduct internal, society-level, and external international expert reviews using surveys with Likert scales and open-ended comments; and (7) issue and update-publish the guideline and monitor literature to assess the need for updates before 5 years. In phase 1, a total of 21 clinical experts and 17 patient and family partners were recruited, and the guideline scope was finalized with 80% to 100% agreement. In phase 2, a total of 23 summary recommendations and 17 new research questions (total=40) were selected. The updated CPG search identified 2 low-quality CPGs, which were excluded from recommendation matching. Of the 17 new research questions, 4 matched existing recommendations. Of the 3 effectiveness questions, one had 7 prioritized outcomes, whereas two had 9 outcomes for inclusion in EtD frameworks. The final CPG is expected by spring 2026, with search strategies, EtD frameworks, and recommendations included. This protocol ensures a transparent Grading of Recommendations Assessment, Development, and Evaluation-based development process, leading to a trustworthy and credible guideline tailored to the European context for managing pain, sedation, delirium, and IWS in children who are critically ill. DERR1-10.2196/67930. [Abstract copyright: ©Ibo MacDonald, Alexia Cavin-Trombert, Cécile Jaques, Gwenaëlle De Clifford-Faugère, Pieter A De Cock, Saskia N de Wildt, Dmytro Dmytriiev, Juliane Engel, Paola Claudia Fazio, Sylvia George, Isabelle Goyer, Anna Harðardóttir, Julia Harris, Klára Horváth, Erwin Ista, Santiago Mencía, Tuuli Metsvaht, Maria Cristina Mondardini, Mehdi Oualha, Maria-Helena Perez, Krzysztof Pietrzkiewicz, Francesca Sperotto, Benjamin Wyness, Nilüfer Yalındağ, Angela Amigoni, Anne-Sylvie Ramelet. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 08.09.2025.]
AB - In pediatric intensive care units, pain, sedation, delirium, and iatrogenic withdrawal syndrome (IWS) must be managed as interrelated conditions. Although clinical practice guidelines (CPGs) exist, new evidence needs to be incorporated, gaps in recommendations addressed, and recommendations adapted to the European context. This protocol describes the development of the first patient- and family-informed European guideline for managing pain, sedation, delirium, and IWS by the European Society of Paediatric and Neonatal Intensive Care. This guideline will follow the Grading of Recommendations Assessment, Development, and Evaluation ADOLOPMENT approach across seven phases: (1) setup-establish 3 groups, namely a steering committee, development panel (experts and patient and family partners), and patient and family partner advisory panel, to define guideline scope through voting and consensus; (2) preparation-vote on 30 summary recommendations compiled from existing CPGs of medium quality or above; prioritize new research questions; update the search for CPGs to match new research questions with recommendations using population, intervention, comparator, and outcome elements; prioritize outcomes for effectiveness questions using a 9-point Likert scale; with validation from patient and family partners; (3) evidence identification, analysis, and data extraction-develop individualized search strategies for each research question (2 independent appraisers will select and appraise studies and conduct data extraction); (4) evidence synthesis-expert pairs will summarize findings in evidence profiles and evidence-to-decision (EtD) frameworks (in the absence of evidence, the expert panel will be surveyed to assess current practices); (5) guideline development-expert pairs will draft recommendations, then topic-specific subgroups will reach consensus before full development panel voting (>80% approval needed; subgroups will determine the need for additional supporting content); (6) review-conduct internal, society-level, and external international expert reviews using surveys with Likert scales and open-ended comments; and (7) issue and update-publish the guideline and monitor literature to assess the need for updates before 5 years. In phase 1, a total of 21 clinical experts and 17 patient and family partners were recruited, and the guideline scope was finalized with 80% to 100% agreement. In phase 2, a total of 23 summary recommendations and 17 new research questions (total=40) were selected. The updated CPG search identified 2 low-quality CPGs, which were excluded from recommendation matching. Of the 17 new research questions, 4 matched existing recommendations. Of the 3 effectiveness questions, one had 7 prioritized outcomes, whereas two had 9 outcomes for inclusion in EtD frameworks. The final CPG is expected by spring 2026, with search strategies, EtD frameworks, and recommendations included. This protocol ensures a transparent Grading of Recommendations Assessment, Development, and Evaluation-based development process, leading to a trustworthy and credible guideline tailored to the European context for managing pain, sedation, delirium, and IWS in children who are critically ill. DERR1-10.2196/67930. [Abstract copyright: ©Ibo MacDonald, Alexia Cavin-Trombert, Cécile Jaques, Gwenaëlle De Clifford-Faugère, Pieter A De Cock, Saskia N de Wildt, Dmytro Dmytriiev, Juliane Engel, Paola Claudia Fazio, Sylvia George, Isabelle Goyer, Anna Harðardóttir, Julia Harris, Klára Horváth, Erwin Ista, Santiago Mencía, Tuuli Metsvaht, Maria Cristina Mondardini, Mehdi Oualha, Maria-Helena Perez, Krzysztof Pietrzkiewicz, Francesca Sperotto, Benjamin Wyness, Nilüfer Yalındağ, Angela Amigoni, Anne-Sylvie Ramelet. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 08.09.2025.]
KW - Practice Guidelines as Topic
KW - Humans
KW - Pain
KW - treatment
KW - Europe
KW - comfort
KW - assessment
KW - critical care
KW - pediatric intensive care
KW - Intensive Care Units, Pediatric
KW - Child
KW - Delirium - therapy
KW - Psychomotor Agitation - therapy
KW - Iatrogenic Disease
KW - Substance Withdrawal Syndrome - therapy
KW - Pain Management - methods - standards
KW - Critical Illness - therapy
U2 - 10.2196/67930
DO - 10.2196/67930
M3 - Article
C2 - 40920438
SN - 1929-0748
VL - 14
JO - JMIR Research Protocols
JF - JMIR Research Protocols
M1 - e67930
ER -